• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌伴转移和不伴转移患者的血清内皮抑素水平。

Serum endostatin levels in patients with metastatic and non-metastatic well-differentiated thyroid cancer.

机构信息

Department of Endocrinology and Diabetology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland.

出版信息

Endokrynol Pol. 2010 Jan-Feb;61(1):7-12.

PMID:20205098
Abstract

INTRODUCTION

The growth of a tumour is limited by its neovascularisation. Angiogenesis is dependent on a dynamic balance between its activators and inhibitors. One of the most important antiangiogenic factors is endostatin. The aim of the study was to assess the usefulness of serum endostatin levels as a potential marker of metastases of well-differentiated thyroid cancer, and to estimate the effect of endogenous TSH stimulation on serum endostatin levels.

MATERIAL AND METHODS

The study group consisted of 68 patients with differentiated thyroid cancer. We provided a cross-sectional analysis of the study group divided into patients with distant and/or locoregional metastases and patients with remission, and compared it with serum endostatin levels of healthy volunteers. Serum endostatin concentration was measured by ELISA kits (R & D Systems).

RESULTS

Median endostatin concentration was significantly higher in patients with distant metastases than in patients with remission (141.95 v. 105.345 ng/ml, p < 0.05). This was not observed in patients with locoregional metastases. Serum endostatin levels were significantly higher in the study group, including patients with remission, than in the control group of healthy volunteers (remission v. healthy median 105.3 v. 88.1 ng/ml, p < 0.05). During endogenous TSH stimulation, endostatin levels significantly decreased (122.94 v. 93.60 ng/ml, p < 0.05).

CONCLUSIONS

The study indicates that endogenous TSH stimulation plays a role in the regulation of endostatin secretion. Although median serum endostatin levels are higher in patients with distant metastases than in patients with remission, its clinical usefulness is limited due to the overlapping data between the study groups. (Pol J Endocrinol 2010; 61 (1): 7-12).

摘要

简介

肿瘤的生长受到其新生血管形成的限制。血管生成依赖于其激活剂和抑制剂之间的动态平衡。最重要的抗血管生成因子之一是内皮抑素。本研究的目的是评估血清内皮抑素水平作为分化型甲状腺癌转移的潜在标志物的有用性,并估计内源性 TSH 刺激对血清内皮抑素水平的影响。

材料和方法

研究组由 68 例分化型甲状腺癌患者组成。我们对研究组进行了横断面分析,分为远处和/或局部转移患者和缓解患者,并与健康志愿者的血清内皮抑素水平进行了比较。采用 ELISA 试剂盒(R & D Systems)测定血清内皮抑素浓度。

结果

远处转移患者的中位内皮抑素浓度明显高于缓解患者(141.95 v. 105.345 ng/ml,p < 0.05)。在局部转移患者中未观察到这种情况。包括缓解患者在内的研究组血清内皮抑素水平明显高于健康志愿者对照组(缓解 v. 健康中位数 105.3 v. 88.1 ng/ml,p < 0.05)。在内源性 TSH 刺激期间,内皮抑素水平显著降低(122.94 v. 93.60 ng/ml,p < 0.05)。

结论

本研究表明内源性 TSH 刺激在调节内皮抑素分泌中起作用。尽管远处转移患者的中位血清内皮抑素水平高于缓解患者,但由于研究组之间的数据重叠,其临床应用受到限制。(波兰内分泌杂志 2010;61(1):7-12)。

相似文献

1
Serum endostatin levels in patients with metastatic and non-metastatic well-differentiated thyroid cancer.分化型甲状腺癌伴转移和不伴转移患者的血清内皮抑素水平。
Endokrynol Pol. 2010 Jan-Feb;61(1):7-12.
2
Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.血清血管内皮生长因子水平在转移性分化型甲状腺癌中升高,但短期促甲状腺激素刺激不会使其升高。
J Clin Endocrinol Metab. 2002 Apr;87(4):1737-42. doi: 10.1210/jcem.87.4.8388.
3
Expression and secretion of endostatin in thyroid cancer.内皮抑素在甲状腺癌中的表达与分泌
Ann Surg Oncol. 2008 Dec;15(12):3601-8. doi: 10.1245/s10434-008-0170-1. Epub 2008 Sep 26.
4
Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.分化型甲状腺癌中的血清可溶性白细胞介素2(IL-2)受体(sIL-2R)
J Endocrinol Invest. 1994 Dec;17(11):861-7. doi: 10.1007/BF03347792.
5
The comparison of serum vascular endothelial growth factor levels between patients with metastatic and non-metastatic thyroid cancer, and patients with nontoxic multinodular goiter.转移性和非转移性甲状腺癌患者与非毒性多结节性甲状腺肿患者血清血管内皮生长因子水平的比较。
Eur J Endocrinol. 2007 Oct;157(4):521-7. doi: 10.1530/EJE-07-0252.
6
Renal metastasis from papillary thyroid microcarcinoma.甲状腺微小乳头状癌的肾转移
Acta Otolaryngol. 2005 Apr;125(4):438-42. doi: 10.1080/00016480410022822.
7
Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.与甲状腺乳头状癌和滤泡状癌远处转移患者生存相关的因素。
Thyroid. 1999 Dec;9(12):1227-35. doi: 10.1089/thy.1999.9.1227.
8
Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.与对照组相比,肾细胞癌患者血清中血管内皮生长因子(VEGF)和内皮抑素的水平。
Eur Urol. 2007 Jan;51(1):168-73; discussion 174. doi: 10.1016/j.eururo.2006.06.026. Epub 2006 Jul 5.
9
Pretreatment serum endostatin as a prognostic indicator in metastatic gastric carcinoma.治疗前血清内皮抑素作为转移性胃癌的预后指标
Int J Cancer. 2006 Dec 15;119(12):2901-6. doi: 10.1002/ijc.22216.
10
Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.全甲状腺切除术后连续测定血清甲状腺球蛋白对分化型甲状腺癌的预后价值
J Endocrinol Invest. 2002 Feb;25(2):110-5. doi: 10.1007/BF03343973.

引用本文的文献

1
Endostatin Stimulates Proliferation and Migration of Myofibroblasts Isolated from Myocardial Infarction Model Rats.内皮抑素刺激心肌梗死后大鼠心肌成纤维细胞的增殖和迁移。
Int J Mol Sci. 2018 Mar 6;19(3):741. doi: 10.3390/ijms19030741.

本文引用的文献

1
Thyroxine as a stimulator of liver regeneration after partial hepatectomy: an experimental animal study.甲状腺素作为部分肝切除术后肝脏再生的刺激因素:一项实验动物研究。
J Egypt Soc Parasitol. 2008 Dec;38(3):853-61.
2
Expression and secretion of endostatin in thyroid cancer.内皮抑素在甲状腺癌中的表达与分泌
Ann Surg Oncol. 2008 Dec;15(12):3601-8. doi: 10.1245/s10434-008-0170-1. Epub 2008 Sep 26.
3
Thyroxine treatment stimulated ovarian follicular angiogenesis in immature hypothyroid rats.
Histol Histopathol. 2008 Nov;23(11):1387-98. doi: 10.14670/HH-23.1387.
4
The comparison of serum vascular endothelial growth factor levels between patients with metastatic and non-metastatic thyroid cancer, and patients with nontoxic multinodular goiter.转移性和非转移性甲状腺癌患者与非毒性多结节性甲状腺肿患者血清血管内皮生长因子水平的比较。
Eur J Endocrinol. 2007 Oct;157(4):521-7. doi: 10.1530/EJE-07-0252.
5
Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model.甲状腺激素及其类似物在三维体外微血管内皮细胞发芽模型中的促血管生成作用
Int Angiol. 2006 Dec;25(4):407-13.
6
Influence of L-thyroxine administration on poor-platelet plasma VEGF concentrations in patients with induced short-term hypothyroidism, monitored for thyroid carcinoma.L-甲状腺素给药对诱导短期甲状腺功能减退症患者(监测甲状腺癌)血小板缺乏血浆VEGF浓度的影响。
Endocr J. 2007 Feb;54(1):63-9. doi: 10.1507/endocrj.k05-112. Epub 2006 Nov 8.
7
Pretreatment serum endostatin as a prognostic indicator in metastatic gastric carcinoma.治疗前血清内皮抑素作为转移性胃癌的预后指标
Int J Cancer. 2006 Dec 15;119(12):2901-6. doi: 10.1002/ijc.22216.
8
Endostatin therapy reveals a U-shaped curve for antitumor activity.内皮抑素疗法显示出抗肿瘤活性的U形曲线。
Cancer Gene Ther. 2006 Jun;13(6):619-27. doi: 10.1038/sj.cgt.7700938.
9
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.癌症治疗中的抗血管生成——内皮抑素及其作用机制。
Exp Cell Res. 2006 Mar 10;312(5):594-607. doi: 10.1016/j.yexcr.2005.11.015. Epub 2005 Dec 22.
10
Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve.内皮抑素的治疗效果呈现出双相剂量反应曲线。
Cancer Res. 2005 Dec 1;65(23):11044-50. doi: 10.1158/0008-5472.CAN-05-2617.